Gerber A - Search Results

1

German diabetes management programs improve quality of care and curb costs.

Stock S, Drabik A, Büscher G, Graf C, Ullrich W, Gerber A, Lauterbach KW, Lüngen M. Stock S, et al. Among authors: gerber a. Health Aff (Millwood). 2010 Dec;29(12):2197-205. doi: 10.1377/hlthaff.2009.0799. Health Aff (Millwood). 2010. PMID: 21134920

2

Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance.

Stock S, Stollenwerk B, Klever-Deichert G, Redaelli M, Büscher G, Graf C, Möhlendick K, Mai J, Gerber A, Lüngen M, Lauterbach KW. Stock S, et al. Among authors: gerber a. Int J Public Health. 2008;53(2):78-86. doi: 10.1007/s00038-008-7026-0. Int J Public Health. 2008. PMID: 18681336 Clinical Trial.

3

Financial incentives in the German Statutory Health Insurance: new findings, new questions.

Stock S, Schmidt H, Büscher G, Gerber A, Drabik A, Graf C, Lüngen M, Stollenwerk B. Stock S, et al. Among authors: gerber a. Health Policy. 2010 Jun;96(1):51-6. doi: 10.1016/j.healthpol.2009.12.015. Epub 2010 Jan 27. Health Policy. 2010. PMID: 20106543

4

Can evidence-based medicine implicitly rely on current concepts of disease or does it have to develop its own definition?

Gerber A, Hentzelt F, Lauterbach KW. Gerber A, et al. J Med Ethics. 2007 Jul;33(7):394-9. doi: 10.1136/jme.2006.017913. J Med Ethics. 2007. PMID: 17601866 Free PMC article. Review.

5

Quantification and classification of errors associated with hand-repackaging of medications in long-term care facilities in Germany.

Gerber A, Kohaupt I, Lauterbach KW, Buescher G, Stock S, Lungen M. Gerber A, et al. Am J Geriatr Pharmacother. 2008 Oct;6(4):212-9. doi: 10.1016/j.amjopharm.2008.10.005. Am J Geriatr Pharmacother. 2008. PMID: 19028377

6

What can we learn from German health incentive schemes?

Schmidt H, Gerber A, Stock S. Schmidt H, et al. Among authors: gerber a. BMJ. 2009 Sep 24;339:b3504. doi: 10.1136/bmj.b3504. BMJ. 2009. PMID: 19778973 No abstract available.

7

Direct non-medical and indirect costs for families with children with congenital cardiac defects in Germany: a survey from a university centre.

Gerber AU, Torre AH, Büscher G, Stock SA, Graf C, Schickendantz S, Brockmeier K, Lüngen M. Gerber AU, et al. Cardiol Young. 2010 Apr;20(2):178-85. doi: 10.1017/S1047951109991995. Epub 2010 Mar 4. Cardiol Young. 2010. PMID: 20199708

8

Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction.

Gerber A, Evers T, Haverkamp H, Lauterbach KW. Gerber A, et al. Eur J Health Econ. 2006 Dec;7(4):247-54. doi: 10.1007/s10198-006-0363-0. Eur J Health Econ. 2006. PMID: 16821072

9

Evidence-based medicine: why do opponents and proponents use the same arguments?

Gerber A, Lauterbach KW. Gerber A, et al. Health Care Anal. 2005 Mar;13(1):59-71. doi: 10.1007/s10728-005-2570-8. Health Care Anal. 2005. PMID: 15889682 Review.

10

Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany.

Lungen M, Stollenwerk B, Messner P, Lauterbach KW, Gerber A. Lungen M, et al. Among authors: gerber a. Int J Equity Health. 2008 Jan 9;7:1. doi: 10.1186/1475-9276-7-1. Int J Equity Health. 2008. PMID: 18184426 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,033 results

Search Page

Filters